Is albuterol (bronchodilator) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albuterol Inhaler is Safe in Pregnancy

Yes, albuterol inhaler is safe to use during pregnancy and is the preferred short-acting bronchodilator because it has the most extensive safety data available. 1, 2

Why Albuterol is Recommended

The most critical principle: Uncontrolled asthma poses a greater risk to the fetus than albuterol itself. Inadequate asthma control can lead to decreased fetal oxygenation, perinatal mortality, preeclampsia, low birth weight, and preterm birth. 1, 2, 3, 4

The NAEPP Expert Panel reviewed data from 6,667 pregnant women (1,929 with asthma, 1,599 who took beta2-agonists) and found reassuring safety data, with more evidence available specifically for albuterol than any other short-acting beta-agonist. 5

Safety Profile

  • Structural anomalies: The risk of birth defects with albuterol is similar to the general population baseline risk of 2-4%. 1
  • Australian TGA Classification A: Salbutamol (albuterol) has the highest safety classification, indicating compatibility during pregnancy. 1
  • Decades of clinical experience: Inhaled asthma medications including albuterol have been used for many years without documented adverse fetal effects. 1

FDA Classification Context

While the FDA labels albuterol as Pregnancy Category C (based on animal studies showing cleft palate in mice at high subcutaneous doses), this should not deter use. 6 Clinical guidelines from the American College of Allergy, Asthma, and Immunology and NAEPP explicitly support albuterol as the first-choice short-acting beta-agonist during pregnancy despite this classification. 2, 5

The animal teratogenicity occurred at doses 1.25-12.5 times the human nebulization dose given subcutaneously—a route and dose not comparable to inhaled therapy. 6 Human case reports of congenital anomalies show no consistent pattern and no established causal relationship. 6

Proper Dosing

  • For quick relief: 2-4 puffs via metered-dose inhaler as needed for symptoms. 5, 2
  • For acute exacerbations: 2.5 mg via nebulizer every 20 minutes for 3 doses, then every 1-4 hours as needed. 1, 2
  • Inhaled route preferred: Systemic administration (oral/IV) should be avoided as it can cause maternal and fetal tachycardia, maternal hyperglycemia, and neonatal hypoglycemia. 1

Monitoring and Red Flags

If albuterol is needed more than twice weekly, this signals inadequate asthma control and requires initiation or escalation of controller therapy (inhaled corticosteroids, preferably budesonide). 5, 2 Using approximately one canister per month indicates poor control even if not using it daily. 5

Monthly evaluation of asthma control and pulmonary function is recommended throughout pregnancy, as symptoms improve in one-third of women and worsen in one-third. 1, 2

Common Pitfalls to Avoid

  • Never withhold albuterol due to pregnancy concerns—this causes more harm to mother and fetus than the medication itself. 7
  • Don't discontinue or de-escalate therapy during pregnancy without clear medical justification, as exacerbations confer additional risk. 4
  • Avoid combining with other sympathomimetic bronchodilators or epinephrine concomitantly. 6
  • Use extreme caution if the patient is on MAO inhibitors or tricyclic antidepressants, as albuterol's vascular effects may be potentiated. 6

Supporting Evidence Quality

The most recent high-quality evidence comes from the American College of Allergy, Asthma, and Immunology guidelines (2025) and a 2023 systematic review in the Journal of Allergy and Clinical Immunology confirming that short-acting beta-agonists and inhaled corticosteroids are safe in pregnancy. 1, 2, 3 A 1994 study specifically demonstrated that maximum recommended doses of inhaled albuterol had no adverse effects on maternal blood pressure, heart rate, uterine blood flow, or fetal circulation. 8

References

Guideline

Salbutamol Safety During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Albuterol Use During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Managing Asthma During Pregnancy and the Postpartum Period.

The journal of allergy and clinical immunology. In practice, 2023

Research

Asthma in Pregnancy.

Obstetrics and gynecology, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Cough in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Short-term effects of inhaled albuterol on maternal and fetal circulations.

American journal of obstetrics and gynecology, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.